Results 111 to 120 of about 35,852 (230)

Nikolsky’s sign - a rare form of alopecia areata

open access: yesVestnik Dermatologii i Venerologii, 2017
Two case reports of rare form of alopecia areata - Nikolsky’s sign - were presented. This disease is often associated with nerve system pathology (schizophrenia, epilepsy, hysteroid reactions). A special feature of first monitoring was the combination of
A. N. Mareeva, I. N. Kondrakhina
doaj   +1 more source

Temporal Trends in Janus Kinase Inhibitor (JAKi) Use Across Five European Countries: A DARWIN EU Network Study

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 11, November 2026.
ABSTRACT Introduction Janus kinase inhibitors (JAKi) are increasingly used for autoimmune conditions despite existing safety concerns. This study aims to estimate the incidence of new JAKi use over time and characterise users in Europe to support future safety studies.
Xihang Chen   +14 more
wiley   +1 more source

The Impact of Molluscum Contagiosum on Depression, Anxiety and Quality of Life in Children

open access: yesThe Journal of Dermatology, Volume 53, Issue 11, Page 1581-1590, November 2026.
ABSTRACT This study aimed to compare depressive symptoms, anxiety symptoms, and health‐related quality of life between children with molluscum contagiosum and healthy controls and to examine whether lesion number and anatomical localization were associated with these outcomes. This prospectively conducted cross‐sectional study included 72 children with
Abdulbaki Artik   +10 more
wiley   +1 more source

Economic Burden and Treatment Patterns Among Patients Diagnosed With Vitiligo in Japan: An Observational Retrospective Cohort Study

open access: yesThe Journal of Dermatology, Volume 53, Issue 11, Page 1615-1625, November 2026.
ABSTRACT Vitiligo, a common and chronic depigmentation disorder, significantly impacts patients' quality of life and exerts a substantial economic burden. The deleterious impact of vitiligo can be exacerbated by comorbid conditions, including psychiatric and autoimmune conditions.
Naoki Oiso   +9 more
wiley   +1 more source

Alopecia areata incognita in Cronkhite-Canada syndrome [PDF]

open access: yes, 2016
Cronkhite-Canada syndrome is an acquired inflammatory polyposis syndrome in which alopecia, onychomadesis and hyperpigmentation occur concurrently with gastrointestinal symptoms.
Rodriguez-Garcia, C   +7 more
core   +1 more source

Risk of venous thromboembolism in chronic inflammatory skin diseases: A retrospective cohort study

open access: yes
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Yael Barer   +6 more
wiley   +1 more source

Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 22, Page 6574-6606, November 2026.
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown   +2 more
wiley   +1 more source

Intralesional triamcinolone acetonide for alopecia areata: does dilution matter?

open access: yes, 2022
Alopecia areata (AA) is a chronic, remitting, non-scarring form of alopecia, which can be associated with significant emotional distress. Intralesional corticosteroids, particularly triamcinolone acetonide, remain first-line therapy in adults with ...
Rui Oliveira Soares, Rebeca Calado
core  

Periorbital Fat Loss From Prostaglandin Analogues: Dermatologic and Cosmetic Considerations

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 11, November 2026.
ABSTRACT Background Topical prostaglandin (PG) analogues, originally developed as first‐line therapies for glaucoma, are increasingly used in dermatology and cosmetic settings to promote eyelash and eyebrow growth. However, their use has been associated with prostaglandin‐associated periorbitopathy (PAP), a constellation of adverse effects including ...
Lily Kaufman   +8 more
wiley   +1 more source

Females Display Greater Disease Severity in a Mouse Model of Vitiligo

open access: yesPigment Cell &Melanoma Research, Volume 39, Issue 6, November 2026.
We compared depigmentation in vitiligo‐prone, h3TA2 mice among males and females, and explored the effects of treatment with HSP70iQ435A plasmid DNA, delivered by biolistic administration. Mice shown from each cohort exemplify increased depigmentation among female mice and the treatment benefit of HSP70iQ435A. ABSTRACT Vitiligo is an autoimmune disease
Kaitlyn G. O'Donnell   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy